Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-21 2021-10-28 145949
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-22 159722
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-26 214241
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-01 2024-03-22 221096
APO-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2018-12-05 2018-12-19 68725
APO-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2019-07-03 2020-01-06 88371
APO-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2022-03-15 2022-05-19 156762
APO-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2023-07-07 2023-09-01 197884
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2017-07-25 2018-03-08 16886
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2020-07-10 89554
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-09-18 2019-11-16 94203
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2020-05-08 2021-03-09 114327
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-09-01 2022-11-20 168353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-09 2023-01-13 177618
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-05-12 2023-09-01 192361
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-23 2023-09-01 196306

Showing 1941 to 1960 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-CLONAZEPAM .5MG TABLET Discontinued 2018-09-07 2018-09-15 60402
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-DICLOFENAC OPHTHALMIC 0.1% SOLUTION Discontinued 2018-09-07 2019-02-13 60426
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40947
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2019-01-04 2019-01-04 71189
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-OLANZAPINE 10.0MG TABLET Discontinued 2018-09-08 2018-12-18 60672

Showing 41 to 60 of 356